Becton, Dickinson and Company (BD) — Vulnerabilities & Security Advisories 9

Becton, Dickinson and Company (BD) develops medical technologies and laboratory equipment, with core use cases in healthcare diagnostics and drug delivery. Historically, common vulnerabilities include remote code execution, cross-site scripting, and privilege escalation, often affecting web interfaces and connected devices. The company maintains a moderate security posture with 9 CVEs on record, though no major public incidents have been widely reported. BD's products, while critical to healthcare, face typical IoT and web application security challenges, requiring ongoing vulnerability management to protect sensitive patient data and maintain operational integrity in clinical environments.